atropine has been researched along with Bone Loss, Osteoclastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El Elshamy, KA; Elwakkad, AS; Sibaii, H | 1 |
| Yamaguchi, M | 1 |
2 other study(ies) available for atropine and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Fish liver oil and propolis as protective natural products against the effect of the anti-epileptic drug valproate on immunological markers of bone formation in rats.
Topics: Alkaline Phosphatase; Animals; Anticonvulsants; Atropine; Biomarkers; Bone Resorption; Disease Models, Animal; Epilepsy; Fish Oils; Male; Osteocalcin; Osteogenesis; Osteoporosis; Osteoprotegerin; Pilocarpine; Propolis; RANK Ligand; Rats; Rats, Sprague-Dawley; Time Factors; Tumor Necrosis Factor-alpha; Valproic Acid | 2008 |
Atropine inhibits bone resorption induced by high dose of zinc in rats.
Topics: Animals; Atropine; Bone and Bones; Bone Resorption; Calcium; Dose-Response Relationship, Drug; Drug Antagonism; Male; Rats; Rats, Inbred Strains; Sulfates; Zinc; Zinc Sulfate | 1983 |